Advanced MedTech (formerly Accuron MedTech Group) is a Singapore-based medical technology company and corporate venture investor. A wholly-owned subsidiary of Temasek Holdings, it makes strategic investments in disruptive medical technology companies alongside its core urology device business.
57% of their portfolio is in Healthcare. Their most common stage is series-b (43% of deals). Average disclosed round size is $10.8M (across 4 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
Morris John
Non-Executive Director
Prof. Sir Edward Byrne
Non-Executive Director
Steven Phan Swee Kim
Non-Executive Director
Veronica McCann
Non-Executive Director
Yau Chung Wong
Group CEO and Executive Director
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| AAWAK Technologies | Series B | — | Sep 2023 |
 SonoMotion | Series C | $12.4M | Nov 2022 |
 Devicare | Series A | — | Jan 2021 |
 ABM Respiratory Care | Series A | $10.3M | Oct 2020 |
 Vivance | Series B | — | — |
 ABM Respiratory Care | Series A | $10.3M | — |
| SonoMotion | Series B | $10M | — |
Top Co-Investors
SEEDS Capital4 shared
Vickers Venture Partners2 shared
Icon Ventures1 shared
Cubit Capital1 shared
Ship2B Ventures1 shared
Caixa Capital Risc1 shared
Ship2B1 shared
Last updated: 20 October 2026